These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 27566796)

  • 1. Familial chilblain lupus due to a gain-of-function mutation in STING.
    König N; Fiehn C; Wolf C; Schuster M; Cura Costa E; Tüngler V; Alvarez HA; Chara O; Engel K; Goldbach-Mansky R; Günther C; Lee-Kirsch MA
    Ann Rheum Dis; 2017 Feb; 76(2):468-472. PubMed ID: 27566796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Clinical Response to Janus Kinase Inhibition in Patients With Familial Chilblain Lupus and TREX1 Mutation.
    Zimmermann N; Wolf C; Schwenke R; Lüth A; Schmidt F; Engel K; Lee-Kirsch MA; Günther C
    JAMA Dermatol; 2019 Mar; 155(3):342-346. PubMed ID: 30673078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial chilblain lupus due to a novel mutation in TREX1 associated with Aicardi-Goutie'res syndrome.
    Yi C; Li Q; Xiao J
    Pediatr Rheumatol Online J; 2020 Apr; 18(1):32. PubMed ID: 32293470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial Chilblain Lupus - What Can We Learn from Type I Interferonopathies?
    Fiehn C
    Curr Rheumatol Rep; 2017 Aug; 19(10):61. PubMed ID: 28844088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Familial chilblain lupus: Four cases spanning three generations].
    Beltoise AS; Audouin-Pajot C; Lucas P; Tournier E; Rice GI; Crow YJ; Mazereeuw-Hautier J
    Ann Dermatol Venereol; 2018 Nov; 145(11):683-689. PubMed ID: 30217686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial chilblain lupus due to a novel mutation in the exonuclease III domain of 3' repair exonuclease 1 (TREX1).
    Günther C; Berndt N; Wolf C; Lee-Kirsch MA
    JAMA Dermatol; 2015 Apr; 151(4):426-31. PubMed ID: 25517357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulated type I IFN response in TREX1-associated familial chilblain lupus.
    Peschke K; Friebe F; Zimmermann N; Wahlicht T; Schumann T; Achleitner M; Berndt N; Luksch H; Behrendt R; Lee-Kirsch MA; Roers A; Günther C
    J Invest Dermatol; 2014 May; 134(5):1456-1459. PubMed ID: 24270665
    [No Abstract]   [Full Text] [Related]  

  • 8. Methods of Assessing STING Activation and Trafficking.
    Pokatayev V; Yan N
    Methods Mol Biol; 2017; 1656():167-174. PubMed ID: 28808969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Type I Interferon Primed Dendritic Cell Subpopulation in TREX1 Mutant Chilblain Lupus Patients.
    Eugster A; Müller D; Gompf A; Reinhardt S; Lindner A; Ashton M; Zimmermann N; Beissert S; Bonifacio E; Günther C
    Front Immunol; 2022; 13():897500. PubMed ID: 35911727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A homozygote TREX1 mutation in two siblings with different phenotypes: Chilblains and cerebral vasculitis.
    Kisla Ekinci RM; Balci S; Bisgin A; Altintas DU; Yilmaz M
    Eur J Med Genet; 2017 Dec; 60(12):690-694. PubMed ID: 28919362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial chilblain lupus--a monogenic form of cutaneous lupus erythematosus due to a heterozygous mutation in TREX1.
    Günther C; Meurer M; Stein A; Viehweg A; Lee-Kirsch MA
    Dermatology; 2009; 219(2):162-6. PubMed ID: 19478477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type I interferonopathies with novel compound heterozygous TREX1 mutations in two siblings with different symptoms responded to tofacitinib.
    Zhang S; Song J; Yang Y; Miao H; Yang L; Liu Y; Zhang X; Liu Y; Wang T
    Pediatr Rheumatol Online J; 2021 Jan; 19(1):1. PubMed ID: 33407657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic involvement in TREX1-associated familial chilblain lupus.
    Günther C; Hillebrand M; Brunk J; Lee-Kirsch MA
    J Am Acad Dermatol; 2013 Oct; 69(4):e179-81. PubMed ID: 24034389
    [No Abstract]   [Full Text] [Related]  

  • 14. Exonuclease TREX1 degrades double-stranded DNA to prevent spontaneous lupus-like inflammatory disease.
    Grieves JL; Fye JM; Harvey S; Grayson JM; Hollis T; Perrino FW
    Proc Natl Acad Sci U S A; 2015 Apr; 112(16):5117-22. PubMed ID: 25848017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of JAK1/2 inhibition in the treatment of chilblain lupus due to TREX1 deficiency.
    Briand C; Frémond ML; Bessis D; Carbasse A; Rice GI; Bondet V; Duffy D; Chatenoud L; Blanche S; Crow YJ; Neven B
    Ann Rheum Dis; 2019 Mar; 78(3):431-433. PubMed ID: 30282666
    [No Abstract]   [Full Text] [Related]  

  • 16. TREX-1-Related Disease Associated with the Presence of Cryofibrinogenemia.
    Paradis C; Cadieux-Dion M; Meloche C; Gravel M; Paradis J; Des Roches A; Leclerc G; Cossette P; Begin P
    J Clin Immunol; 2019 Jan; 39(1):118-125. PubMed ID: 30685859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autosomal dominant inheritance of a heterozygous mutation in SAMHD1 causing familial chilblain lupus.
    Ravenscroft JC; Suri M; Rice GI; Szynkiewicz M; Crow YJ
    Am J Med Genet A; 2011 Jan; 155A(1):235-7. PubMed ID: 21204240
    [No Abstract]   [Full Text] [Related]  

  • 18. Heterozygous TREX1 p.Asp18Asn mutation can cause variable neurological symptoms in a family with Aicardi-Goutieres syndrome/familial chilblain lupus.
    Abe J; Izawa K; Nishikomori R; Awaya T; Kawai T; Yasumi T; Hiragi N; Hiragi T; Ohshima Y; Heike T
    Rheumatology (Oxford); 2013 Feb; 52(2):406-8. PubMed ID: 22829693
    [No Abstract]   [Full Text] [Related]  

  • 19. Familial chilblain lupus in a child with heterozygous mutation in SAMHD1 and normal interferon signature.
    Linggonegoro DW; Song H; Jones KM; Lee PY; Schmidt B; Vleugels RA; Huang JT
    Br J Dermatol; 2021 Sep; 185(3):650-652. PubMed ID: 33887057
    [No Abstract]   [Full Text] [Related]  

  • 20. Brief Report: Blockade of TANK-Binding Kinase 1/IKKɛ Inhibits Mutant Stimulator of Interferon Genes (STING)-Mediated Inflammatory Responses in Human Peripheral Blood Mononuclear Cells.
    Frémond ML; Uggenti C; Van Eyck L; Melki I; Bondet V; Kitabayashi N; Hertel C; Hayday A; Neven B; Rose Y; Duffy D; Crow YJ; Rodero MP
    Arthritis Rheumatol; 2017 Jul; 69(7):1495-1501. PubMed ID: 28426911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.